MORGAN STANLEY PLC/CALL/STRYKER CORP./430/0.1/20.06.25 Stock

Warrant

DE000ME9BQC0

Market Closed - Börse Stuttgart 02:11:57 2024-06-07 pm EDT
1.01 EUR +5.21% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./430/0.1/20.06.25
Current month+12.94%
1 month+33.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-07 1.01 +5.21%
24-06-06 0.96 +1.05%
24-06-05 0.95 +6.74%
24-06-04 0.89 +7.23%
24-06-03 0.83 -2.35%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 02:11 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME9BQC
ISINDE000ME9BQC0
Date issued 2024-02-27
Strike 430 $
Maturity 2025-06-20 (378 Days)
Parity 10 : 1
Emission price 1.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.03
Lowest since issue 0.61
Spread 0.04
Spread %3.77%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
349.6 USD
Average target price
373.1 USD
Spread / Average Target
+6.70%
Consensus